top of page
grey-9026_256.gif

Established, $1.2 Million Revenue ABA Therapy in the Northeast U.S.

Listing Code:

XYBH2O

State:

Not Disclosed

Category:

Behavioral Health, Mental Health, & ABA Therapy

Asking Price:

-

Revenue:

$1,200,000

XYBH2O
Company Overview

PRIME exits® and American Healthcare Capital are pleased to exclusively introduce a privately owned ABA Therapy company for sale in the Northeast U.S. The company is a regional provider of insurance and private funded Applied Behavior Analysis services in the Northeastern U.S., offering in‑home, community‑based, and remote clinical programs for children and young adults. The company focuses on natural‑environment teaching, family and school collaboration, and technology‑enabled tracking of individualized treatment plans. Services include comprehensive assessments, behavior plans, early intervention, social skills programs, functional and safety skills training, and parent training, delivered by clinically supervised teams.

Payer Breakdown and Current Market

The current Payer Breakdown is 80% Medicaid and 20% Insurance. The payer environment is supportive: state mandates and public insurance cover medically necessary ABA services, including social skills groups, without annual or lifetime dollar caps when criteria are met, underpinning stable demand dynamics in the company’s operating footprint. The broader U.S. ABA market is a multi‑billion‑dollar sector with steady growth and a significant home‑based therapy component.

Financial Overview

The company has demonstrated exceptional revenue momentum, growing from $1 million in 2024 to $1.2 million in 2025, which is a 16% increase. The company’s operational strength is evident in its adjusted EBITDA performance, growing from $53,000 to $154,000 (+290%) from 2022 to 2025. This represents a healthy 13% EBITDA margin at scale, demonstrating sustainable unit economics, and leaving space to improve with more attention to expenses and operations efficiency.

Exit Plan

The Seller seeks a majority sale or a 100% acquisition, with the option to include the real estate. Key operators and staff are remaining to support the business expansion. The Owner is open to staying on to run the business long term or for a transition period.

Asking Price

The purchase price to be determined through mutual discussions with the seller.   

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

XYBH2O

Listing Title:

Established, $1.2 Million Revenue ABA Therapy in the Northeast U.S.

Heading 4

Need to learn more before Signing an NDA- Contact the Lead Advisor For This Mandate

Listing Title:

Error
Error

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About us
 

PRIME exits®—a registered trademark of Nazeri & Company LLC and its independent subsidiary Nazeri & Company Co., Ltd.(Thailand). Our firm focus is representing founder led and legacy companies across healthcare, engineering, Manufacturing, Robotics and Automation.

 

Locations

Los Angeles

Las Vegas

Bangkok

Vancouver, BC

Milan, Italy

Contact us

 

1-800- 424-3388 HEAD OFFICE

1-310-625-7889 Jack Eskenazi

1-702-506-3392 Dr. Allen Nazeri 

Valuation Team

Jack@ahcteam.com 

Allen@ahcteam.com

Paul@pexits.com

(Healthcare Only)

(Healthcare & Others)

(Healthcare & Others)

bottom of page